Viridian Therapeutics, Inc. (NASDAQ: VRDN) Stock Information | RedChip

Viridian Therapeutics, Inc. (NASDAQ: VRDN)


$22.1650
-0.0050 ( -0.02% ) 263.4K

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

Market Data


Open


$22.1650

Previous close


$22.1700

Volume


263.4K

Market cap


$1.69B

Day range


$21.6660 - $22.3850

52 week range


$11.4000 - $25.3850

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 13, 2023
8-k 8K-related 15 Nov 13, 2023
10-q Quarterly Reports 69 Nov 13, 2023
8-k 8K-related 14 Nov 02, 2023
3 Insider transactions 2 Nov 01, 2023
4 Insider transactions 1 Nov 01, 2023
3 Insider transactions 2 Nov 01, 2023
4 Insider transactions 1 Nov 01, 2023
4 Insider transactions 1 Nov 01, 2023
8-k 8K-related 16 Oct 30, 2023

Latest News